AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32000140 — intervention group
Group type: COMPARATOR
Intervention: Combined resisted sprint
Number of subjects: 48
Study 32000140 — intervention group
Group type: COMPARATOR
Intervention: Unresisted sprint
Number of subjects: 48
Study 33345953 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% oxygen at 10 L/min until delivery
Number of subjects: 117
Study 33345953 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 117
Study 34117383 — intervention group
Group type: EXPERIMENTAL
Intervention: Tecnis +2.75 D (ZKB00) (MIOL Group)
Number of subjects: 29
Study 34117383 — intervention group
Group type: EXPERIMENTAL
Intervention: Tecnis Symfony (ZXR00) (EDOF Group)
Number of subjects: 29
Study 33177149 — intervention group
Group type: EXPERIMENTAL
Intervention: EBP training
Number of subjects: 110
Study 33177149 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile applications usage
Number of subjects: 110
Study 36171701 — intervention group
Group type: EXPERIMENTAL
Intervention: Orem's Self‐Care Deficit Theory (OSCDT) based education and telephone follow‐ups
Number of subjects: 47
Study 36171701 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing care (Control)
Number of subjects: 47
Study 34521493 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes self-management education (DSME)
Number of subjects: 77
Study 34521493 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 77
Study 36236307 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy Drink (ED)
Number of subjects: 24
Study 36236307 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 35222905 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body photobiomodulation (PBM) therapy programme
Number of subjects: 44
Study 35222905 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 32590517 — intervention group
Group type: EXPERIMENTAL
Intervention: Supercharge end-to-side anterior interosseous nerve-to-ulnar motor nerve transfer
Number of subjects: 42
Study 36435547 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE)
Number of subjects: 92
Study 36435547 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 92
Study 36435547 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation Therapy (RT)
Number of subjects: 92
Study 36435547 — intervention group
Group type: COMPARATOR
Intervention: All treatment groups (PE, IPT, RT)
Number of subjects: 92
Study 34472231 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral recombinant human insulin (400 μU/ml mixed with enteral feeding)
Number of subjects: 33
Study 34472231 — intervention group
Group type: COMPARATOR
Intervention: Placebo added to formula
Number of subjects: 33
Study 34472231 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral recombinant human insulin
Number of subjects: 33
Study 34472231 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 34472231 — intervention group
Group type: COMPARATOR
Intervention: Enteral recombinant human insulin and Placebo
Number of subjects: 33
Study 36307891 — intervention group
Group type: EXPERIMENTAL
Intervention: Leader education program
Number of subjects: 148
Study 36307891 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 148
Study 33153829 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient counseling plus vouchers for attendance (VOU)
Number of subjects: 460
Study 33153829 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient counseling plus text reminders (REM)
Number of subjects: 460
Study 33153829 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient counseling plus vouchers and text reminders (REM + VOU)
Number of subjects: 460
Study 33153829 — intervention group
Group type: COMPARATOR
Intervention: Standard outpatient counseling only (STD)
Number of subjects: 460
Study 32438316 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation training in research design
Number of subjects: 0
Study 36045446 — intervention group
Group type: EXPERIMENTAL
Intervention: Myofascial release protocol applied to the cervical spine
Number of subjects: 0
Study 36045446 — intervention group
Group type: COMPARATOR
Intervention: Placebo light touch protocol
Number of subjects: 0
Study 32461138 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vitamin D (25,000 IU weekly for 26 weeks)
Number of subjects: 143
Study 32461138 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143
Study 35985201 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct care by co-located psychiatrists
Number of subjects: 191
Study 35985201 — intervention group
Group type: COMPARATOR
Intervention: Collaborative care (primary care clinicians supported by psychiatrists)
Number of subjects: 191
Study 35212487 — intervention group
Group type: EXPERIMENTAL
Intervention: XELOX
Number of subjects: 448
Study 35212487 — intervention group
Group type: COMPARATOR
Intervention: EOX
Number of subjects: 448
Study 35693272 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopy combined with choledochoscopy
Number of subjects: 86
Study 35693272 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 86
Study 33606419 — intervention group
Group type: EXPERIMENTAL
Intervention: Predetermined volumes of a feeding-drink (Nutricia Nutridrink) between 50 and 400 ml
Number of subjects: 72
Study 33606419 — intervention group
Group type: EXPERIMENTAL
Intervention: New model using the antral cross-sectional area in the right-lateral decubitus position
Number of subjects: 72
Study 33780930 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group increased TWI to 3.7 L for males and 2.7 L for females for 14 days.
Number of subjects: 23
Study 33780930 — intervention group
Group type: COMPARATOR
Intervention: Control group maintained habitual low TWI.
Number of subjects: 23
Study 33780930 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (experimental and control) measured for changes in blood volume (BV) and total body water (TBW).
Number of subjects: 23
Study 35429718 — intervention group
Group type: EXPERIMENTAL
Intervention: SAFMEDS intervention
Number of subjects: 40
Study 35429718 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study 32731750 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobilisation with movement and usual care (exercise and moist heat)
Number of subjects: 40
Study 32731750 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 40
Study 615920826 — intervention group
Group type: EXPERIMENTAL
Intervention: Besivance (3 times a day for 10 days)
Number of subjects: 24
Study 615920826 — intervention group
Group type: COMPARATOR
Intervention: Polytrim (3 times a day for 10 days)
Number of subjects: 24
Study 36054314 — intervention group
Group type: EXPERIMENTAL
Intervention: RLRL-RLRL group
Number of subjects: 114
Study 36054314 — intervention group
Group type: EXPERIMENTAL
Intervention: SVS-RLRL group
Number of subjects: 114
Study 36054314 — intervention group
Group type: EXPERIMENTAL
Intervention: RLRL-SVS group
Number of subjects: 114
Study 36054314 — intervention group
Group type: COMPARATOR
Intervention: SVS-SVS group
Number of subjects: 114
Study 34132739 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous CoNS‐AM+ (n = 5)
Number of subjects: 11
Study 34132739 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (n = 6)
Number of subjects: 11
Study 34132739 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous CoNS‐AM+
Number of subjects: 11
Study 34132739 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 11
Study 35587843 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity NPPV
Number of subjects: 24
Study 35587843 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity NPPV
Number of subjects: 24
Study 34939397 — intervention group
Group type: EXPERIMENTAL
Intervention: Herb-partitioned moxibustion combined with electroacupuncture (43 ± 1) ℃, 3 times per week for 12 weeks
Number of subjects: 60
Study 34939397 — intervention group
Group type: COMPARATOR
Intervention: Control group received herb-partitioned moxibustion (37 ± 1) ℃ and sham electroacupuncture
Number of subjects: 60
Study 34737096 — intervention group
Group type: EXPERIMENTAL
Intervention: Navigation group (NG) - 2-dimensional navigation guidance used for vertebral body screw placement.
Number of subjects: 40
Study 34737096 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - No navigation guidance used for vertebral body screw placement.
Number of subjects: 40
Study 34737096 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (NG and CG)
Number of subjects: 40
Study 34737096 — intervention group
Group type: EXPERIMENTAL
Intervention: Navigation group (NG)
Number of subjects: 40
Study 34126130 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 3991
Study 34126130 — intervention group
Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 3991
Study 32988827 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftolozane/tazobactam (C/T)
Number of subjects: 4
Study 32988827 — intervention group
Group type: COMPARATOR
Intervention: Meropenem
Number of subjects: 4
Study 34232470 — intervention group
Group type: EXPERIMENTAL
Intervention: c-tDCS
Number of subjects: 21
Study 34232470 — intervention group
Group type: COMPARATOR
Intervention: SHAM stimulation
Number of subjects: 21
Study 33370228 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical cord blood (UCB) transfusion
Number of subjects: 1651
Study 33184928 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan (TCC) exercise, 35-40 min/session, twice a week for 12 weeks
Number of subjects: 20
Study 32590491 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived overqualification
Number of subjects: 1456
Study 32590491 — intervention group
Group type: EXPERIMENTAL
Intervention: Turnover intention
Number of subjects: 1456
Study 35844026 — intervention group
Group type: EXPERIMENTAL
Intervention: Anlotinib
Number of subjects: 101
Study 35844026 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 33819215 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodex balance training and traditional exercise programme
Number of subjects: 48
Study 33819215 — intervention group
Group type: COMPARATOR
Intervention: Traditional exercise programme
Number of subjects: 48
Study 35727681 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.07% CPC (Vitis CPC Protect) mouthwash
Number of subjects: 118
Study 35727681 — intervention group
Group type: COMPARATOR
Intervention: colored distilled water (placebo)
Number of subjects: 118
Study 32580771 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 421
Study 32580771 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate-amodiaquine (ASAQ)
Number of subjects: 421
Study 35886495 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental commitment
Number of subjects: 0
Study 35886495 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental commitment with high social norms
Number of subjects: 0
Study 35886495 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticipated pride and anticipated guilt
Number of subjects: 0
Study 35886495 — intervention group
Group type: EXPERIMENTAL
Intervention: Social norms
Number of subjects: 0
Study 32761620 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin tests (STs) for metronidazole/ornidazole
Number of subjects: 49
Study 32761620 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-blind placebo-controlled drug provocation tests (SBPCDPTs)
Number of subjects: 49
Study 32761620 — intervention group
Group type: EXPERIMENTAL
Intervention: Basophil activation test (BAT) for metronidazole
Number of subjects: 49
Study 32761620 — intervention group
Group type: EXPERIMENTAL
Intervention: Basophil activation test (BAT) for ornidazole
Number of subjects: 49
Study 32761620 — intervention group
Group type: EXPERIMENTAL
Intervention: No cross-reactivity observed between metronidazole and ornidazole according to in vivo tests.
Number of subjects: 49
Study 35357704 — intervention group
Group type: EXPERIMENTAL
Intervention: Guidewire group (using a SWARTZ sheath and a Brockenbrough needle with a 0.014‐inch coronary guidewire)
Number of subjects: 200
Study 35357704 — intervention group
Group type: COMPARATOR
Intervention: Contrast group (using standard devices and injecting contrast to confirm needle-tip position)
Number of subjects: 200
Study 32777710 — intervention group
Group type: EXPERIMENTAL
Intervention: Lady Health Worker (LHW) facilitated community engagement and early diagnosis, stabilization and referral of women with preeclampsia
Number of subjects: 39446
Study 33883152 — intervention group
Group type: COMPARATOR
Intervention: Wait-and-see approach
Number of subjects: 15
Study 32886666 — intervention group
Group type: EXPERIMENTAL
Intervention: Change Agents (CAs)
Number of subjects: 458
Study 32886666 — intervention group
Group type: COMPARATOR
Intervention: NMs (social network members)
Number of subjects: 458
Study 616782744 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol plus Trimetazidine (Met+Tri)
Number of subjects: 200
Study 616782744 — intervention group
Group type: COMPARATOR
Intervention: Control (no Met+Tri)
Number of subjects: 200
Study 36029132 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg)
Number of subjects: 21
Study 36029132 — intervention group
Group type: COMPARATOR
Intervention: Placebo (grapefruit juice)
Number of subjects: 21
Study 33339752 — intervention group
Group type: EXPERIMENTAL
Intervention: Graduated medical elastic thigh compression stocking for 14 days
Number of subjects: 44
Study 33339752 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment for 14 days
Number of subjects: 44
Study 33031270 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg of VASO6 (green tea extract)
Number of subjects: 30
Study 33031270 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 g L-citrulline malate and 3 g L-arginine hydrochloride
Number of subjects: 30
Study 33031270 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 35113311 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective laser trabeculoplasty (SLT)
Number of subjects: 21
Study 33170969 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed support including vasopressor use
Number of subjects: 79
Study 33170969 — intervention group
Group type: COMPARATOR
Intervention: Traditional volume-based support
Number of subjects: 79
Study 33170969 — intervention group
Group type: COMPARATOR
Intervention: Traditional volume-based support (soft tissue flaps)
Number of subjects: 79
Study 33170969 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed support including vasopressor use (soft tissue flaps)
Number of subjects: 79
Study 33170969 — intervention group
Group type: COMPARATOR
Intervention: Traditional volume-based support (bony flaps)
Number of subjects: 79
Study 33170969 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed support including vasopressor use (bony flaps)
Number of subjects: 79
Study 36155238 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional working memory training (EWMT)
Number of subjects: 40
Study 36155238 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 40
Study 32723859 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable Oxygen Concentrator (POC)
Number of subjects: 30
Study 32723859 — intervention group
Group type: COMPARATOR
Intervention: Portable Compressed Oxygen Cylinder
Number of subjects: 30
Study 34011710 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative follow-up at Day 3-7 and Day 25-30 after a mandatory Day 0 examination
Number of subjects: 848
Study 34011710 — intervention group
Group type: COMPARATOR
Intervention: Postoperative follow-up directly at Day 25-30 after a mandatory Day 0 examination
Number of subjects: 848
Study 33263954 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 0
Study 33263954 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 35131452 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab plus vemurafenib plus cobimetinib
Number of subjects: 514
Study 35131452 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo plus vemurafenib plus cobimetinib)
Number of subjects: 514
Study 34053786 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital Breast Tomosynthesis (DBT)
Number of subjects: 28749
Study 34053786 — intervention group
Group type: COMPARATOR
Intervention: Digital Mammography (DM)
Number of subjects: 28749
Study 32887873 — intervention group
Group type: EXPERIMENTAL
Intervention: Elotuzumab plus lenalidomide/dexamethasone (ERd)
Number of subjects: 646
Study 32887873 — intervention group
Group type: COMPARATOR
Intervention: Lenalidomide/dexamethasone (Rd)
Number of subjects: 646
Study 35683359 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.6 µg/kg/h)
Number of subjects: 80
Study 35683359 — intervention group
Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 80
Study 35683359 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Dexmedetomidine and Control)
Number of subjects: 80
Study 36191176 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile mental health apps (4 different apps used for 4 weeks)
Number of subjects: 0
Study 36191176 — intervention group
Group type: EXPERIMENTAL
Intervention: Using the app at least once a week
Number of subjects: 0
Study 36191176 — intervention group
Group type: COMPARATOR
Intervention: Control app (most usable)
Number of subjects: 0
Study 36191176 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile mental health apps
Number of subjects: 0
Study 33956802 — intervention group
Group type: EXPERIMENTAL
Intervention: 99DOTS-based treatment supervision
Number of subjects: 1913
Study 33956802 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment supervision (control)
Number of subjects: 1913
Study 32285723 — intervention group
Group type: COMPARATOR
Intervention: Hospitals with an absolute volume of 22-36 PKRs per year
Number of subjects: 18134
Study 32285723 — intervention group
Group type: COMPARATOR
Intervention: Hospitals with an absolute volume of 36-58 PKRs per year
Number of subjects: 18134
Study 32285723 — intervention group
Group type: COMPARATOR
Intervention: Hospitals with more than 58 PKRs per year
Number of subjects: 18134
Study 32285723 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospitals with fewer than 22 PKRs per year
Number of subjects: 18134
Study 33904665 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive music therapy (using small percussive instruments, guitar, voice, and recorder) applied individually before baseline ultrasound scan, oocyte pick-up, and embryo transfer.
Number of subjects: 113
Study 33904665 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive music therapy
Number of subjects: 113
Study 33904665 — intervention group
Group type: COMPARATOR
Intervention: Control Group (no intervention)
Number of subjects: 113
Study 34032852 — intervention group
Group type: EXPERIMENTAL
Intervention: Nontasters
Number of subjects: 1935
Study 34032852 — intervention group
Group type: COMPARATOR
Intervention: Supertasters
Number of subjects: 1935
Study 34032852 — intervention group
Group type: COMPARATOR
Intervention: Tasters
Number of subjects: 1935
Study 35286456 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 41
Study 35286456 — intervention group
Group type: COMPARATOR
Intervention: Tacrolimus
Number of subjects: 41
Study 33109386 — intervention group
Group type: EXPERIMENTAL
Intervention: Hetrombopag 7.5-mg tablets administered with high-fat, high-calorie food
Number of subjects: 12
Study 33109386 — intervention group
Group type: COMPARATOR
Intervention: Hetrombopag 7.5-mg tablets administered in the fasted state
Number of subjects: 12
Study 35945292 — intervention group
Group type: EXPERIMENTAL
Intervention: Flowcharts for periodontal diagnosis
Number of subjects: 152
Study 35945292 — intervention group
Group type: COMPARATOR
Intervention: Consensus reports
Number of subjects: 152
Study 34287856 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral anticoagulation therapy (PACT)
Number of subjects: 8845
Study 33160812 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring (education intervention plus mobile self-monitoring with email feedback)
Number of subjects: 40
Study 33160812 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined (education and monitoring interventions plus social cognitive theory-based behavioral videos)
Number of subjects: 40
Study 33160812 — intervention group
Group type: COMPARATOR
Intervention: Education (educational videos and handouts)
Number of subjects: 40
Study 33160812 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall mHealth programs
Number of subjects: 40
Study 33347677 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIg (2 g/kg over 4 days)
Number of subjects: 50
Study 33347677 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 33347677 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIg
Number of subjects: 50
Study 33151749 — intervention group
Group type: EXPERIMENTAL
Intervention: Circuit Resistance Training (CRT)
Number of subjects: 40
Study 33151749 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 33969554 — intervention group
Group type: EXPERIMENTAL
Intervention: C. mas extract (3 capsules of 300 mg per day for 8 weeks)
Number of subjects: 84
Study 33969554 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3 capsules of 300 mg starch powder per day for 8 weeks)
Number of subjects: 84
Study 34176735 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-mode survey (via email or letter with website)
Number of subjects: 239
Study 34176735 — intervention group
Group type: COMPARATOR
Intervention: Paper survey (via mail)
Number of subjects: 239
Study 34176735 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-mode survey
Number of subjects: 239
Study 34176735 — intervention group
Group type: COMPARATOR
Intervention: Paper survey
Number of subjects: 239
Study 34837999 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based stress management training (iSMT)
Number of subjects: 0
Study 34837999 — intervention group
Group type: COMPARATOR
Intervention: In-person group-based stress management training (gSMT)
Number of subjects: 0
Study 34962055 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based mobile intervention (10-15 minutes per day for 8 weeks)
Number of subjects: 64
Study 34962055 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 64